Tech Firm Partners with NYU to Test 3D Surgical Platform for Thrombectomy

A firm that develops next-generation 3D digital surgery platforms is partnering with NYU Langone Health Division of Neuroradiology to test the company’s tool (Surgical Cognition Platform; Medical iSight, New York, NY) for visualizing and navigating image-guided removal of blood clots after stroke or blood vessel repair after an aneurysm.

The platform gives surgeons enhanced ability to look inside patients and visualize their blood vessels, bones, and internal organs from a variety of vantage points using 3D visualization and surgical guidance software and Microsoft HoloLens mixed-reality headsets. It is designed to improve procedures that require a catheter in the groin or wrist, which must be guided through blood vessels to the damaged area.

Medical iSight is working with NYU Langone's interventional radiologists and neurosurgeons to improve preoperative planning navigation during surgical procedures, which is intended to speed clot removal and reduce ischemic tissue damage in stroke victims.

"We are delighted to be working with NYU Langone Health and their world-class doctors to advance our groundbreaking interventional software and deliver on our vision to unite surgical digital information within a single cognitive platform, to make it universally accessible, thereby resulting in better patient outcomes,” said Justin Hall-Tipping, CEO, Medical iSight.

NYU has disclosed an equity interest in Medical iSight as part of this collaboration.